Role of β blocker and angiotensin antagonist for the prophylaxis of early onset anthracycline-induced ventricular dysfunction: A meta-analysis of five randomized controlled trials.

Abstract

1021 Background: Anthracycline is one of the most effective and commonly used chemotherapeutic agents in patients with breast cancer, Hodgkin and non-Hodgkin lymphomas. However, it is associated wi...